MAPT and Alzheimer disease: AD and stroke share numerous pathophysiological changes in brain tissue, such as hypoperfusion, oxidative stress, immune exhaustion, inflammation, and abnormal expression of amyloid β and tau proteins13, which together may lead to altered neurotransmission, synaptic loss, neurodegeneration, and a resulting decline in cognitive ability (i.e., dementia)14.